期刊文献+

肝动脉介入化疗栓塞治疗肝癌的临床疗效观察 被引量:6

Clinical Observation of Hepatic Arterial Infusion Chemotherapy Embolization in the Treatment of Liver Cancer
下载PDF
导出
摘要 目的:探讨肝癌患者行肝动脉栓塞化疗的临床效果。方法:选取2010年1月-2012年12月期间在本院住院治疗的70例中晚期肝细胞肝癌患者为研究对象。根据患者及其家属的意愿,将70例患者分为观察组35例和对照组35例,观察组接受肝动脉介入化疗栓塞,对照组采用口服索拉非尼治疗。治疗3个月后比较两组患者的临床治疗效果。结果:观察组患者在治疗3个月后治疗的总有效率82.86%明显高于对照组患者的57.14%,比较差异有统计学意义(P<0.05)。观察组平均生存期(29.42±5.39)个月明显长于对照组的(16.46±3.82)个月,差异有统计学意义(P<0.05)。结论:经肝动脉化疗栓塞治疗肝细胞肝癌能有效控制疾病的快速发展,延长患者的生命。 Objective: To investigate the clinical effect of hepatic artery chemoembolization for liver cancer patients.Method: January 2010 to December 2012 in our hospital 70 patients with advanced hepatocellular carcinoma were selected as the research objects.According to the wishes of patients and their families, 70 patients were divided into the observation group for 35 cases and the control group for 35 cases, the observation group was treated with hepatic arterial infusion chemotherapy embolism, the control group was treated with oral sorafenib treatment.Clinical effect in patients after 3 months of treatment were compared between the groups.Result: After 3 months of treatment, the total effective rate of observation group was 82.86%, significantly higher than the comrol group of 57.14%, the difference was statistically significant ( P〈0.05 ) . The average survival period of observation group ( 29.42 ± 5.39 ) months was longer than that in the control aroun ( 16.46± 3.82 ) months, the difference was statistically signifieant ( P〈0.05 ) Conclusion: Transcatheter arterial chemoembolization treatment of hepatocellular carcinoma can effectively control the rapid development of the disease and prolong the lives of patients.
作者 王赢
出处 《中国医学创新》 CAS 2013年第28期103-105,共3页 Medical Innovation of China
关键词 肝动脉栓塞 介入 化疗 放射 Hepatic artery embolization Intervention Chemotherapy Radiation
  • 相关文献

参考文献11

二级参考文献120

共引文献129

同被引文献51

  • 1Stuart KE,Anand AJ,Jenkins RL.Hepatocellular carcino- ma in the United States.Prognostic features ,treatment out- come, and survival[J].Cancer, 1996,77 ( 11 ) : 2217-2222.
  • 2Pirisi M,Avellini C,Fabris C,et al.Portal vein thrombosis in hepatocellular carcinoma:age and sex distribution in an autopsy study[J].J Cancer Res Clin Oncol, 1998,124 (7) : 397-400.
  • 3中国抗癌协会.新编常见恶性肿瘤诊治规范-原发性肝癌分册[M].北京:北京医科大学,中国协和医科大学联合出版社,1999:389-479.
  • 4殷蔚伯,谷铣之.肿瘤放疗治疗学[M].4版.北京:中国协和医科大学出版社,2008:829-836.
  • 5Lawrence TS,Dworzanin LM,Walker-Andrews SC,et al. Treatment of cancers involving the liver and portal hepatic with external irradiation and intraarterial hepatic fluo- rodeoxyuridine[J].Int J Radiat Oneol B iol Phys, 1991,20(3) : 555-561.
  • 6Robertson JM,Lawrene TS,Wolker S,et al.The treatment of eolorectalliver metastases with conformal radiation ther apy and regional ehemotherapy[J].Int J Radiat Oncol Biol Phys, 1995,32(2) :445-450.
  • 7Lawrence TS,Ten Haken RK,Kessler ML,et al.The use of 3-D dose volume analysis to predict radiation hepatitis[J].Int J Radiat Oncol Biol Phys, 1992,23(4):781-788.
  • 8Lujan AE,Balter JM,Ten Haken RK,et al.A method for incorporating organ motion due to breathing into 3D dose calculations in the liver:sensitivity to variations in motion[J]. Med Phys, 2009,30 (10) : 2643-2649.
  • 9Ten Haken RK,Bolter JM,Marsh LH,et al.Potential ben- efits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors[J].Int J Radiat Oncol Biol Phys, 1997,38 (3) : 613-617.
  • 10Huang T S, Shyu Y C, Chen H Y, et al. A systematic review and meta- analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma[J].J Viral Hepat, 2013, 20(10): 729-743.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部